IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SARAH LUREE ANSBRO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1063702637
CMS profile
1331153
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$4,595.17

  • Reported across 308 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$921.97

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $909.82 50
Education $12.15 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $222.71 11
ABBVIE INC. $194.03 15
Lundbeck LLC $103.45 4
Teva Pharmaceuticals USA, Inc. $77.96 4
Neurocrine BioSciences, Inc. $68.59 4
Otsuka America Pharmaceutical, Inc. $66.36 4
Vanda Pharmaceuticals Inc. $55.35 3
Supernus Pharmaceuticals, Inc. $36.39 2
Janssen Pharmaceuticals, Inc $32.70 1
Axsome Therapeutics, Inc. $32.35 1
Takeda Pharmaceuticals U.S.A., Inc. $32.08 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $772.54 59
PY2019 $1,106.95 83
PY2020 $147.99 14
PY2021 $514.11 38
PY2022 $358.79 23
PY2023 $772.82 40
PY2024 $921.97 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $8.88 02/01/2024 Food and Beverage Undisputed 01/23/2026 1103910328 CMS
ABBVIE INC. $13.05 02/05/2024 Food and Beverage Undisputed 01/23/2026 1103910330 CMS
ABBVIE INC. $8.20 02/21/2024 Food and Beverage Undisputed 01/23/2026 1103910332 CMS
ABBVIE INC. $17.64 03/04/2024 Food and Beverage Undisputed 01/23/2026 1103910334 CMS
ABBVIE INC. $15.57 03/07/2024 Food and Beverage Undisputed 01/23/2026 1103910336 CMS
ABBVIE INC. $11.70 04/22/2024 Food and Beverage Undisputed 01/23/2026 1103910338 CMS
ABBVIE INC. $11.13 05/15/2024 Food and Beverage Undisputed 01/23/2026 1103910340 CMS
ABBVIE INC. $9.68 06/26/2024 Food and Beverage Undisputed 01/23/2026 1103910342 CMS
ABBVIE INC. $12.17 08/13/2024 Food and Beverage Undisputed 01/23/2026 1103910344 CMS
ABBVIE INC. $27.67 08/19/2024 Food and Beverage Undisputed 01/23/2026 1103910346 CMS
ABBVIE INC. $7.08 08/28/2024 Food and Beverage Undisputed 01/23/2026 1103910348 CMS
ABBVIE INC. $20.78 09/10/2024 Food and Beverage Undisputed 01/23/2026 1103910350 CMS
ABBVIE INC. $7.79 09/19/2024 Food and Beverage Undisputed 01/23/2026 1103910352 CMS
ABBVIE INC. $15.24 10/15/2024 Food and Beverage Undisputed 01/23/2026 1103910354 CMS
ABBVIE INC. $7.45 10/17/2024 Food and Beverage Undisputed 01/23/2026 1103910356 CMS
Axsome Therapeutics, Inc. $32.35 12/03/2024 Food and Beverage Undisputed 01/23/2026 1148319152 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.19 01/08/2024 Food and Beverage Undisputed 01/23/2026 1143242467 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.23 01/18/2024 Food and Beverage Undisputed 01/23/2026 1143242471 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.70 02/01/2024 Food and Beverage Undisputed 01/23/2026 1143242474 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.70 02/20/2024 Food and Beverage Undisputed 01/23/2026 1143242478 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.15 05/01/2024 Education Undisputed 01/23/2026 1143242482 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.53 05/01/2024 Food and Beverage Undisputed 01/23/2026 1143242485 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.83 05/08/2024 Food and Beverage Undisputed 01/23/2026 1143242489 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.14 06/26/2024 Food and Beverage Undisputed 01/23/2026 1143242493 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.42 08/06/2024 Food and Beverage Undisputed 01/23/2026 1143242496 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $33.86 10/08/2024 Food and Beverage Undisputed 01/23/2026 1143242500 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.96 10/23/2024 Food and Beverage Undisputed 01/23/2026 1143242504 CMS
Janssen Pharmaceuticals, Inc $32.70 05/16/2024 Food and Beverage Undisputed 01/23/2026 1078212617 CMS
Lundbeck LLC $27.82 06/19/2024 Food and Beverage Undisputed 01/23/2026 1145924692 CMS
Lundbeck LLC $32.07 10/01/2024 Food and Beverage Undisputed 01/23/2026 1145924694 CMS
Lundbeck LLC $17.58 11/05/2024 Food and Beverage Undisputed 01/23/2026 1145924696 CMS
Lundbeck LLC $25.98 12/17/2024 Food and Beverage Undisputed 01/23/2026 1145924698 CMS
Neurocrine Biosciences, Inc. $21.29 01/31/2024 Food and Beverage Undisputed 01/23/2026 1150853791 CMS
Neurocrine Biosciences, Inc. $15.91 03/25/2024 Food and Beverage Undisputed 01/23/2026 1150872460 CMS
Neurocrine Biosciences, Inc. $17.57 09/17/2024 Food and Beverage Undisputed 01/23/2026 1150866927 CMS
Neurocrine Biosciences, Inc. $13.82 10/30/2024 Food and Beverage Undisputed 01/23/2026 1150877956 CMS
Otsuka America Pharmaceutical, Inc. $14.82 01/09/2024 Food and Beverage Undisputed 01/23/2026 1118908135 CMS
Otsuka America Pharmaceutical, Inc. $20.19 03/20/2024 Food and Beverage Undisputed 01/23/2026 1118908137 CMS
Otsuka America Pharmaceutical, Inc. $16.50 05/21/2024 Food and Beverage Undisputed 01/23/2026 1118908139 CMS
Otsuka America Pharmaceutical, Inc. $14.85 07/03/2024 Food and Beverage Undisputed 01/23/2026 1118908141 CMS
Supernus Pharmaceuticals, Inc. $21.87 05/04/2024 Food and Beverage Undisputed 01/23/2026 1147890931 CMS
Supernus Pharmaceuticals, Inc. $14.52 08/27/2024 Food and Beverage Undisputed 01/23/2026 1147896155 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.35 02/06/2024 Food and Beverage Undisputed 01/23/2026 1137575297 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.73 09/03/2024 Food and Beverage Undisputed 01/23/2026 1137575301 CMS
Teva Pharmaceuticals USA, Inc. $14.90 01/25/2024 Food and Beverage Undisputed 01/23/2026 1151610818 CMS
Teva Pharmaceuticals USA, Inc. $26.81 02/21/2024 Food and Beverage Undisputed 01/23/2026 1151610832 CMS
Teva Pharmaceuticals USA, Inc. $23.02 07/24/2024 Food and Beverage Undisputed 01/23/2026 1151610884 CMS
Teva Pharmaceuticals USA, Inc. $13.23 08/15/2024 Food and Beverage Undisputed 01/23/2026 1151610886 CMS
Vanda Pharmaceuticals Inc. $23.92 05/07/2024 Food and Beverage Undisputed 01/23/2026 1133906023 CMS
Vanda Pharmaceuticals Inc. $17.98 08/20/2024 Food and Beverage Undisputed 01/23/2026 1133906025 CMS
Vanda Pharmaceuticals Inc. $13.45 11/12/2024 Food and Beverage Undisputed 01/23/2026 1133906027 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.